[1]
Zribi, A., Al Riyami, K., Al Zahibi, H.S. and Burney, I.A. 2023. Managing the Adverse Events Associated with the Combination Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer. Sultan Qaboos University Medical Journal. 1, 1 (Sep. 2023). DOI:https://doi.org/10.18295/squmj.9.2023.057.